Zimbabwe has rejected a major US healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years because of Washington's demand for confidential biological samples.
This move became public following a official document from December was disclosed, which showed Head of State Emmerson Mnangagwa believed the agreement was "skewed".
A government spokesman has since explained that the US was demanding access to biological samples for research and commercial gain while was unwilling to guarantee the resulting advantages from future treatments.
"We will now turn to the difficult and regrettable process of winding down our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged more dialogue to secure a deal agreeable to all parties so the nation's critical HIV treatment initiative can be sustained.
Broader Background
This development follows a similar situation in Kenya, where a court halted a similar deal with the US following concerns were raised about the safety of citizens' medical information.
After resuming the presidency last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump stated its spending was "wasteful" and his government was pursuing direct bilateral deals to boost openness and responsibility.
According to reports, Sixteen nations in Africa have so far agreed to these new health pacts, constituting more than $18.3bn in new funding.
Details of the Rejected Agreement
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership would have delivered immense benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment via American-funded programmes," Tremont commented.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to share its genetic material and health information for a long time, with no corresponding assurance of access to any medical innovations – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.
"Put simply, our country would supply the raw materials for medical research with no certainty that the final treatments would be accessible to our population if a future pandemic arise."
National Interest and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were disrupting structures previously established via the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to manage potential pandemics.
"This system is designed to ensure that when a nation contributes its data, the benefits – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to further dialogue with our American counterparts on how future collaboration could be arranged in a manner that honours the sovereignty and dignity of each country."
Health Experts Response
Medical experts said it recognised the official position, but urged that negotiations need to persist given that a large portion of the nation's HIV programmes relied on external financing.
"In cases where specific concerns arise, including those involving information security or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," it commented.
The situation highlights the continuing challenges between receiving much-needed international aid and protecting local interests in an ever more interconnected world.